Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection: Repeat analyses with updated data for the prospective cohort study in the Netherlands from July 2021 to June 2022.

Huiberts, Anne J; van den Hof, Susan; Knol, Mirjam J

Huiberts, Anne J; van den Hof, Susan; Knol, Mirjam J.

Afiliação

Huiberts AJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
van den Hof S; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands.
Knol MJ; Centre for Infectious Disease Control, National Institute for Public Health and Environment (RIVM), Bilthoven, the Netherlands. Electronic address: mirjam.knol@rivm.nl.

Int J Infect Dis ; 146: 107127, 2024 Sep.

Article em En | MEDLINE | ID: mdl-38901730

Assuntos

Vacinas contra COVID-19; COVID-19; Imunização Secundária; SARS-CoV-2; Eficácia de Vacinas; Humanos; COVID-19/prevenção & controle; COVID-19/epidemiologia; Países Baixos/epidemiologia; Vacinas contra COVID-19/imunologia; Vacinas contra COVID-19/administração & dosagem; SARS-CoV-2/imunologia; Estudos Prospectivos; Adulto; Masculino; Pessoa de Meia-Idade; Feminino; Vacinação; Idoso

Palavras-chave

COVID-19; SARS-CoV-2; Vaccine effectiveness

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunização Secundária / Vacinas contra COVID-19 / SARS-CoV-2 / COVID-19 / Eficácia de Vacinas Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google